#46
|
||||
|
||||
Òóäà æå íîâàÿ ñòóäèÿ ïî òðîìáýêòîìèè â ðàñøèðåííîì âðåìåííîì îêíå:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#47
|
||||
|
||||
Íîâîå â ëå÷åíèè ñèíäðîìà ëåííîêñ-ãàñòî? Çàÿâêà íà ðàçðåøåíèå ê ïðèìåíåíèþ ïîäàíà
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#48
|
||||
|
||||
 ïîëíîì òåêñòå î êàííàáèíîèäàõ â ëå÷åíèè ýïèëåïñèè çäåñü:
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#49
|
||||
|
||||
Î, êàê â òåìó, â èþëüñêîì âûïóñêå ñòàòüÿ ýïèëåïñèÿ+ãîëîâíàÿ áîëü!!
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#50
|
||||
|
||||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ëåâèòåðàöåòàì â ñðàâíåíèè ñ ôåíîáàðáèòàëîì â ëå÷åíèè ýïèëåïñèè ó äåòåé |
#51
|
||||
|
||||
J Alzheimers Dis. 2018;62(2):561-570.
Homocysteine and Dementia: An International Consensus Statement. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#52
|
|||
|
|||
Ãàéäëàéí ïî ëå÷åíèþ îñòðîé èøåìèè ãîëîâíîãî ìîçãà AHA/ASA 2018
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
|
#53
|
||||
|
||||
ïäô âåðñèÿ ýòîãî ãàéäà óæå èìååòñÿ â ñîîá. 44
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#54
|
||||
|
||||
Îò ðåçèñòåíòíîé ýïèëåïñèè ê ðåçèñòåíòíîé êëàñòåðíîé ãîëîâíîé áîëè: êàê ìîäèôèöèðîâàííàÿ äèåòà Àòêèíñà ïîìîãàåò ñïðàâëÿòüñÿ ñ ýòèì íåäóãîì:
Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm, Clinical Trial. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#55
|
||||
|
||||
Èíòåðåñíîå ïðèìåíåíèå íàøëîñü äëÿ êóðàíòèëà: èñïàíöû ïðîòåñòèðîâàëè è íàøëè ýôôåêòèâíûì ïðè ñèíäðîìå áåñïîêîéíûõ íîã - ñðåäíÿÿ ðàáî÷àÿ äîçà: îäèííàäöàòü (!!!) òàáëåòîê â äåíü, ÷òî ñîïðîâîæäàëîñü ñïàçìàìè â æèâîòå, ïðèëèâàìè è ïðî÷. ïîá. äåéñòâèåì, ïðèñóùèì äèïèðèäàìîëó:
Sleep Med. 2018 May;45:94-97. Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#56
|
||||
|
||||
òðàíåêñàì ïðè âíóòðè÷åðåïíîì êðîâîèçëèÿíèè: â öåëîì íåò íèêàêèõ ïðåèìóùåñòâ ïåðåä ïëàöåáî, íî ïîõîæå ìîæíî îæèäàòü ëó÷øèé ïðîãíîç, åñëè ÑÀÄ ìåíåå 170 è ðàçìåð ãåìàòîìû ìåíåå 60 ìë; òðàíåêñàì ñïîñîáñòâîâàë ìèíèìèçàöèè ãåìàòîìû, íî áûòü ìîæåò ïîçäíåå ââåäåíèå (ó áîëüøèíñòâà ïîçæå 3 ÷) ãåìàòîìà ñíèçèëàñü âñåãî íà 1.4 ìë, ÷òî áûëî íåäîñòàòî÷íûì äëÿ âëèÿíèÿ íà ïðîãíîç:
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial Lancet. 2018 May 15. pii: S0140-6736(18)31033-X. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#57
|
||||
|
||||
Ôàðìàêîðåçèñòåíòíàÿ ýïèëåïñèÿ, íîâûå íàõîäêè íà ïðèìåðå êàðáàìàçåïèíà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#58
|
||||
|
||||
Anticoagulation Resumption After Intracerebral Hemorrhage.
Curr Atheroscler Rep. 2018 May 21;20(7):32. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#59
|
||||
|
||||
Íå ñîòâîðè ñåáå ïðîáëåìó...
Acute beriberi neuropathy mimicking Guillain-Barré syndrome after a strict vegetarian diet [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#60
|
||||
|
||||
Of 609 patients younger than 60 years who presented with stroke or TIA, there were 161 abnormalities in hematocrit level or platelet count in 153 patients (25.1%). One hundred sixteen patients had high hematocrit levels (19%), 19 had thrombocytosis (3.1%), 26 had thrombocytopenia (4.3%), and 8 had abnormalities in both lineages (1.3%). A total of 119 patients had repeat testing (74%). Molecular investigations for MPD were warranted in 19 patients (3.1%), performed in 3 patients (.5%) with 2 patients subsequently diagnosed. ADAMTS13 analysis was indicated in 10 patients with thrombocytopenia, performed in 2 patients with 1 diagnosed with TTP thereafter.
--- J Stroke Cerebrovasc Dis. 2018 Jul 5. pii: S1052-3057(18)30228-3. The Importance of the Full Blood Count in Cerebral Ischemia: A Review of 609 Consecutive Young Patients with Stroke and Transient Ischemic Attacks
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |